AUS
NZ
UK
CA
USA
IND
Healthcare
Creso Pharma Is Set To Enter Sri Lanka’s Medicinal Cannabis Industry
January 07, 2019 07:10 PM AEDT| By Team Kalkine MediaAs per ASX announcement dated 7 January 2019, Creso Pharma Limited (ASX: CPH) has signed a Letter of Intent with Ceyoka Health Private Limited, Srilanka?s leading medical distribution company, for geographical expansion of medicinal cannabis across t...
Immutep Limited Enters Into Clinical Trial Collaboration
January 07, 2019 05:45 PM AEDT| By Team Kalkine MediaTo test eftilagimod alpha as part of a cancer peptide vaccine discovered by artificial intelligence new clinical trial collaboration with CYTLIMIC has been performed. With their cancer vaccine product candidate including efti, it builds on Immutep Li...
Kazia’s Presentation To Biotech Showcase Stated Achievement Of All Milestones For 2018– A Quick Look
January 07, 2019 04:52 PM AEDT| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) operates as a biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and development technology solutions. Kazia Therapeutics serves customers globally. The co...
Cynata Therapeutics Got Notice Of Acceptance From IP Australia For Cymerus Patent Application
January 07, 2019 03:18 PM AEDT| By Team Kalkine MediaOn 7 January 2019, Cynata Therapeutics (ASX: CYP) came forward and made an announcement about the Notice of Acceptance which it had got from IP Australia. Dr. Paul Wotton is presently acting as the company's Chairman while Dr. Ross Macdonald is actin...
Healius Board Rejected Jangho Hong Kong’s Acquisition Proposal – What You Need To Know
January 07, 2019 03:07 PM AEDT| By Team Kalkine MediaFormerly known as Primary Health Care Ltd, Australia's leading healthcare company Healius Limited (ASX: HLS) has rejected the acquisition proposal from Jangho Hong Kong Holdings Limited. Following this news, the share price of HLS decreased by 5.818...
Mesoblast’s Stock Soars On ASX Following The Completion Of Patient Recruitment In Phase Three Trial
January 07, 2019 02:13 PM AEDT| By Team Kalkine MediaMesoblast Limited (ASX: MSB) is into innovation of cellular medicines. It develops off the shelf cellular drugs.? It has a diversified portfolio of cell-based and most clinically advanced products. The company has its technology platform of mesenchym...
Bionomics Begins The Clinical Trial Of Cancer Drug BNC105
January 04, 2019 07:21 PM AEDT| By Team Kalkine MediaBionomics Limited (ASX: BNO) is a bio-pharma company under the health care sector based out in Thebarton, Australia. The company is engaged in developing better treatments for cancer, central nervous system disorders (including anxiety and depression...
GI Dynamics Appointed New Vice President of Clinical and Regulatory Affairs
January 04, 2019 07:10 PM AEDT| By Team Kalkine MediaMedical device company, GI Dynamics Inc (ASX:GID) has appointment highly experienced Mr. Stephen Linhares as the new Vice President of clinical and regulatory affairs. As Vice President of clinical and regulatory affairs at GI Dynamics, Mr. Linhares...
REVA Medical Announces New CFO
January 04, 2019 07:10 PM AEDT| By Team Kalkine MediaOn January 4, 2019, REVA Medical, Inc. (ASX: RVA) has made a public announcement that Ms. Leigh Elkolli will become a new CFO (Chief Financial Officer) and Corporate Secretary, which will be effective from today. Earlier Brandi Roberts held the posit...
Capitol Health: Daily Share Buyback Update
January 04, 2019 04:04 PM AEDT| By Team Kalkine MediaCapitol Health Ltd (ASX: CAJ) is a leading player in the Australian healthcare market segment, offering diagnostic image services via clinics established in Tasmania, Melbourne and Victoria. As per an ASX announcement dated 18 August 2017, Capitol H...
Resonance Health Soars On Acquiring The Use Of Licensed Patents
January 03, 2019 11:12 PM AEDT| By Team Kalkine MediaResonance Health shares sky-rocketed after the company announced the execution of license agreement for the use of patents. The stock price jumped as high as 54.098% to last trade at $0.094 on 3 January 2019. And if the stock continues to move with t...
IMC’s Shares Uplifted On ASX After Receiving R&D Tax Concession Refund Of $1.19 Million
January 03, 2019 09:29 PM AEDT| By Team Kalkine MediaAustralian microbiome biopharmaceutical company, Immuron Limited (ASX: IMC) made an announcement on 3 January 2019 stating that it has received a cash refund of $1.19 million under the Australian Government?s Research and Development Income Tax Conce...
Healius Limited’s Shares Uplifted On ASX After Receiving Acquisition Offer From Jangho Hong Kong Ltd
January 03, 2019 01:56 PM AEDT| By Team Kalkine MediaHealius Limited (ASX: HLS), formerly known as Primary Health Care Ltd, ?is one of Australia's leading healthcare company which provides world-class facilities and support services to healthcare professionals. On 3 January 2019, Healius Limited made a...
Starpharma's Product, VivaGel Condom Grabs Final Regulatory Approval For Japan
January 02, 2019 05:25 PM AEDT| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) had made an announcement related to the regulatory approval with respect to VivaGel condom by the issuance of the press release. Starpharma happens to be in the business of developing dendrimer products for the...
GI DYNAMICS, INC Provides An Extension Of The Maturity Date Of US $5M Convertible Note
January 02, 2019 04:51 PM AEDT| By Team Kalkine MediaGI DYNAMICS, INC (ASX: GID) is to extend the maturity date of its 2017 Senior Secured Convertible Promissory Note from 31 December 2018 to 31 March 2019 and is pleased to announce that it has reached an agreement with Crystal Amber Fund Limited. Esse...
Creso Pharma Set To Take Benefit of Israeli Parliament’s Approval: What You Need To Know
January 02, 2019 03:51 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) had made an announcement related to the approval which has been provided by Israeli Parliament with the help of the press release. As per the press release dated January 2, 2019, the company had stated that the approva...
ResApp Unlocks The Last Step To Commercialize Its Diagnostic Mobile Application In Europe
January 02, 2019 03:28 PM AEDT| By Team Kalkine MediaDigital Health company ResApp Health Limited (ASX: RAP) submits its CE Mark Technical File to the British Standard Institution (BSI) for a first-of-its-kind smartphone application, ResAppDx, developed for the diagnosis and management of respiratory d...
MMJ Group’s MediPharm Labs Added To HMMJ
December 31, 2018 11:36 PM AEDT| By Team Kalkine MediaMMJ?s partially held cannabis extractor MediPharm Labs has been included in the Horizons Marijuana Life Sciences Index ETF, listed on the Toronto Stock Exchange (TSX: HMMJ). Canadian medical cannabis oil production facility MediPharm Labs today annou...
The Share Price Of ONE Remains Unaffected To The Directorship Change
December 31, 2018 10:25 PM AEDT| By Team Kalkine MediaOneview Healthcare PLC (ASX: ONE) on 31 December 2018, announced that Mark Cullen resigned from the Board of Directors and his resignation will be effective from 04 January 2019. He will be joining DWS Group GmbH as an executive board member. As a pa...
What Made The Two Healthcare Stocks Climbing High – BLT And PBT?
December 31, 2018 01:43 PM AEDT| By Team Kalkine MediaPrana Biotechnology Limited (ASX: PBT) Prana Biotechnology Limited (ASX: PBT), a company from the health care industry which is into the business of developing first-in-class therapies for orphan neurodegenerative diseases announced its securities...
Advertise your brand on Kalkine Media